This Medical Moment Episode 1 – Facial Recognition in Rare Diseases

On average, a patient with a rare disease takes 4.8 years to find a correct diagnosis. For patients and families searching for answers, this wait can be agonizing. FDNA’s Face2Gene technology is helping to change the standard of care and shorten the time to diagnosis – all through the use of a smartphone.

PRECISIONeffect President Carolyn Morgan is joined by Dekel Gelbman, former CEO of FDNA, to discuss:

  • The pain points in effectively diagnosing rare diseases amongst HCPs and patients
  • How artificial intelligence (AI) is changing the standard of care and shortening the time to diagnosis in rare disease 
  • How FDNA is shifting HCP behaviors and beliefs to drive adoption and use of their smartphone technology  
  • Health equality and how smartphone technology and AI can help bridge the gap.

Never Miss a Medical Moment

The most extraordinary moments in medicine are happening right now, but will these innovations get the opportunity to change lives?

Stay in the know and be the first to watch new episodes of This Medical Moment.

Carolyn

Advancements are happening in every corner of medicine. Brilliant new innovations are upending traditional thinking and power structures in the development of treatments and the delivery of care.

Join Carolyn Morgan in This Medical Moment and learn how others are overcoming the obstacles. She will be joined by guests who are leading critical changes in the standards of care.

What’s coming next? Find out. In a moment.

Beginning May 20, 2024, the Precision Value & Health family of brands is becoming Precision AQ.

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life changing medicines. Our global offerings include:
  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights. To find out more about our global services and our unified mission, to empower access to life-changing medicines for all, visit: Precision AQ

Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.